Cann GroupASX:CAN +12.50% Cash Ratio is 0.05 as of Dec. 2025, which is 94% below its 10-year median of 0.85. The stock has 7 warning signs investors should review. Among 977 Drug Manufacturers companies, Cann Group ranks worse than 90.38% on this metric.
Cann Group has a Cash Ratio of 0.05. It indicates that there are more current liabilities than Cash, Cash Equivalents, Marketable Securities, and the company does not have sufficient cash on hand to pay off its short-term debt.
The historical rank and industry rank for Cann Group's Cash Ratio or its related term are showing as below:
ASX:CAN'
s Cash Ratio Range Over the Past 10 Years
Min: 0.02 Med: 0.85 Max: 87.43
Current: 0.05
During the past 9 years, Cann Group's highest Cash Ratio was 87.43. The lowest was 0.02. And the median was 0.85.
ASX:CAN's Cash Ratio is ranked worse than 90.38% of 977
companies
in the Drug Manufacturers industry
Industry Median: 0.61
vs ASX:CAN: 0.05
Cann Group (ASX:CAN) Cash Ratio Explanation
The cash ratio is more conservative than other liquidity ratios, such as Quick Ratio and Current Ratio, because it only considers a company's most liquid resources. The numerator of cash ratio only considers Cash, Cash Equivalents and marketable securities. Other current assets, such as accounts receivable and inventories, are not included. The rationale is that these assets may require time to be transformed into cash, and the amount of money received is also uncertain.
The cash ratio shows a company’s ability to pay all current liabilities immediately without selling or liquidating other assets. Generally speaking, a higher cash ratio suggests the company has a stronger ability to cover its short-term debt. However, a high cash ratio could also indicate inefficient management: the company is inefficient in making full utilization of cash to invest protential profitable project. It may also suggest that the company is not confident about future profitability.
In general, the higher the cash ratio, the better the company's liquidity position.
Cann Group Cash Ratio Related Terms
Cann Group Cash Ratio Historical Data
* Premium members only.
The historical data trend for Cann Group's Cash Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Cann Group's Cash Ratio, along with its competitors' market caps and Cash Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Cann Group Cash Ratio vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Cann Group's Cash Ratio distribution charts can be found below:
* The bar in red indicates where Cann Group's Cash Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Cann Group (ASX:CAN) has a Cash Ratio of 0.05 as of Dec. 2025. Cashflow ratio is the ratio of Cash, Cash Equivalents, Marketable Securities to current liabilities. View historical data on Cann Group and its competitors. This is 94% below median its historical median of 0.85. Over the past decade, Cann Group's Cash Ratio has ranged from 0.02 to 87.43. According to the industry distribution chart, Cann Group ranks #883 out of 977 companies in the Drug Manufacturers industry, placing it in the top 90.4%.
Is Cann Group's Cash Ratio too high?
Cann Group's current Cash Ratio of 0.05 is 94% below median its 10-year median of 0.85. Over the past 10 years, this metric has ranged from a low of 0.02 to a high of 87.43. The Drug Manufacturers industry median Cash Ratio is 0.61. Cann Group's value of 0.05 is 91.8% below this industry median. Based on the distribution chart, Cann Group ranks #883 out of 977 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers.
How does Cann Group's Cash Ratio compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Cann Group ranks #883 out of 977 companies for Cash Ratio. This places Cann Group in the lower half of its industry. The industry median Cash Ratio is 0.61. Cann Group's value of 0.05 is 91.8% below this benchmark. Historically, Cann Group's own Cash Ratio has ranged from 0.02 to 87.43 over the past decade. While the company's 10-year median is 0.85 vs. the industry median of 0.61, Cann Group has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Ratio for a Drug Manufacturers company?
The median Cash Ratio among Drug Manufacturers companies is 0.61, based on 977 companies in the industry. Companies in the top quartile (top 25%) have a Cash Ratio significantly above this median, while those in the bottom quartile fall well below. However, Cash Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Cann Group's current Cash Ratio of 0.05 is 91.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Ratio mean?
A high Cash Ratio can signal that a stock is expensive relative to its fundamentals. Cashflow ratio is the ratio of Cash, Cash Equivalents, Marketable Securities to current liabilities. View historical data on Cann Group and its competitors. For the Drug Manufacturers industry, the median Cash Ratio is 0.61 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Cann Group's current Cash Ratio is 0.05, which is 94% below median its own 10-year median of 0.85. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cann Group stock overvalued right now?
Based on GuruFocus' analysis, Cann Group (ASX:CAN) is currently considered Possible Value Trap. The stock's GF Value™ is A$0.02, compared to a current price of A$0.00 — trading 77.5% below its estimated fair value. The current Cash Ratio is 0.05, which is 94% below median its 10-year median of 0.85 and 91.8% below the Drug Manufacturers industry median of 0.61. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Ratio calculated?
Cash Ratio is calculated from a company's financial statements. For Cann Group (ASX:CAN), the current Cash Ratio is 0.05 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Cann Group Ltd is engaged in the cultivation of medicinal cannabis for both medicinal and research purposes under the licenses and permits issued to the company, the development and manufacture (via third-party arrangements) of finished product formulations. Geographically, the company operates in Europe and Australia. The company derives maximum revenue from Australia.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:CAN has been successfully added to your 